Abstract
Acanthamoeba amoebae of genotype T2 were identified as the causative agent of Acanthamoeba skin lesions and granulomatous amoebic encephalitis (GAE) in a human immunodeficiency virus-negative patient with underlying tuberculosis. To our knowledge this, is the first case of GAE involving genotype T2.
MeSH terms
-
Acanthamoeba / classification
-
Acanthamoeba / genetics
-
Acanthamoeba / isolation & purification*
-
Adult
-
Amebiasis / drug therapy
-
Amebiasis / parasitology
-
Amebiasis / pathology*
-
Amikacin / therapeutic use
-
Animals
-
Antiprotozoal Agents / therapeutic use
-
Antitubercular Agents / therapeutic use
-
DNA, Protozoan / chemistry
-
DNA, Protozoan / genetics
-
Encephalitis / drug therapy
-
Encephalitis / parasitology*
-
Encephalitis / pathology
-
Genotype
-
HIV Infections / complications
-
Humans
-
Male
-
Molecular Sequence Data
-
Phosphorylcholine / analogs & derivatives
-
Phosphorylcholine / therapeutic use
-
Sequence Analysis, DNA
-
Skin Diseases, Parasitic / parasitology
-
Skin Diseases, Parasitic / pathology
-
Tuberculosis / complications
Substances
-
Antiprotozoal Agents
-
Antitubercular Agents
-
DNA, Protozoan
-
Phosphorylcholine
-
miltefosine
-
Amikacin